vs
NewtekOne, Inc.（NEWT）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是NewtekOne, Inc.的1.0倍（$75.5M vs $73.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -2.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-579.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 12.2%）
纽泰克是一家总部位于美国得克萨斯州圣安东尼奥的软硬件企业，专注于为个人电脑提供直播、后期制作视频工具及视觉成像软件。公司由蒂姆·杰尼森与保罗·蒙哥马利于1985年在美国堪萨斯州托皮卡创立，2019年4月宣布被Vizrt收购。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NEWT vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.0倍
$73.3M
营收增速更快
PBYI
高出30.4%
-2.7%
自由现金流更多
PBYI
多$593.7M
$-579.3M
两年增速更快
PBYI
近两年复合增速
12.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $73.3M | $75.5M |
| 净利润 | $19.5M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 111.8% | — |
| 营收同比 | -2.7% | 27.7% |
| 净利润同比 | 6.6% | — |
| 每股收益（稀释后） | $0.64 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEWTPBYI
| Q4 25 | $73.3M | $75.5M | ||
| Q3 25 | $74.9M | $54.5M | ||
| Q2 25 | $70.2M | $52.4M | ||
| Q1 25 | $66.3M | $46.0M | ||
| Q4 24 | $75.4M | $59.1M | ||
| Q3 24 | $62.8M | $80.5M | ||
| Q2 24 | $61.1M | $47.1M | ||
| Q1 24 | $58.3M | $43.8M |
净利润NEWTPBYI
| Q4 25 | $19.5M | — | ||
| Q3 25 | $17.9M | $8.8M | ||
| Q2 25 | $13.7M | $5.9M | ||
| Q1 25 | $9.4M | $3.0M | ||
| Q4 24 | $18.3M | — | ||
| Q3 24 | $11.9M | $20.3M | ||
| Q2 24 | $10.9M | $-4.5M | ||
| Q1 24 | $9.7M | $-4.8M |
毛利率NEWTPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率NEWTPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率NEWTPBYI
| Q4 25 | 111.8% | — | ||
| Q3 25 | 23.9% | 16.2% | ||
| Q2 25 | 19.5% | 11.2% | ||
| Q1 25 | 14.1% | 6.5% | ||
| Q4 24 | 24.3% | — | ||
| Q3 24 | 19.0% | 25.2% | ||
| Q2 24 | 17.9% | -9.6% | ||
| Q1 24 | 16.6% | -11.0% |
每股收益（稀释后）NEWTPBYI
| Q4 25 | $0.64 | $0.26 | ||
| Q3 25 | $0.67 | $0.17 | ||
| Q2 25 | $0.52 | $0.12 | ||
| Q1 25 | $0.35 | $0.06 | ||
| Q4 24 | $0.70 | $0.40 | ||
| Q3 24 | $0.45 | $0.41 | ||
| Q2 24 | $0.43 | $-0.09 | ||
| Q1 24 | $0.38 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $819.9M | $22.7M |
| 股东权益账面价值 | $397.6M | $130.3M |
| 总资产 | $2.7B | $216.3M |
| 负债/权益比越低杠杆越低 | 2.06× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NEWTPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务NEWTPBYI
| Q4 25 | $819.9M | $22.7M | ||
| Q3 25 | $748.5M | $34.0M | ||
| Q2 25 | $657.3M | $45.3M | ||
| Q1 25 | $774.0M | $56.7M | ||
| Q4 24 | $708.0M | $68.0M | ||
| Q3 24 | $655.8M | $79.3M | ||
| Q2 24 | $652.0M | $90.7M | ||
| Q1 24 | $662.5M | $102.0M |
股东权益NEWTPBYI
| Q4 25 | $397.6M | $130.3M | ||
| Q3 25 | $386.7M | $115.3M | ||
| Q2 25 | $312.2M | $104.7M | ||
| Q1 25 | $302.3M | $97.1M | ||
| Q4 24 | $296.3M | $92.1M | ||
| Q3 24 | $281.8M | $71.1M | ||
| Q2 24 | $274.0M | $48.5M | ||
| Q1 24 | $254.1M | $51.0M |
总资产NEWTPBYI
| Q4 25 | $2.7B | $216.3M | ||
| Q3 25 | $2.4B | $202.9M | ||
| Q2 25 | $2.1B | $194.9M | ||
| Q1 25 | $2.1B | $196.2M | ||
| Q4 24 | $2.1B | $213.3M | ||
| Q3 24 | $1.7B | $220.7M | ||
| Q2 24 | $1.6B | $205.0M | ||
| Q1 24 | $1.5B | $214.1M |
负债/权益比NEWTPBYI
| Q4 25 | 2.06× | 0.17× | ||
| Q3 25 | 1.94× | 0.30× | ||
| Q2 25 | 2.11× | 0.43× | ||
| Q1 25 | 2.56× | 0.58× | ||
| Q4 24 | 2.39× | 0.74× | ||
| Q3 24 | 2.33× | 1.12× | ||
| Q2 24 | 2.38× | 1.87× | ||
| Q1 24 | 2.61× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-579.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-579.3M | $14.4M |
| 自由现金流率自由现金流/营收 | -790.0% | 19.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.0% |
| 现金转化率经营现金流/净利润 | -29.64× | — |
| 过去12个月自由现金流最近4个季度 | $-1.0B | $41.7M |
8季度趋势，按日历期对齐
经营现金流NEWTPBYI
| Q4 25 | $-579.2M | $14.4M | ||
| Q3 25 | $-167.3M | $9.7M | ||
| Q2 25 | $-199.8M | $14.1M | ||
| Q1 25 | $-60.7M | $3.6M | ||
| Q4 24 | $-153.0M | $15.6M | ||
| Q3 24 | $-25.7M | $11.0M | ||
| Q2 24 | $2.9M | $1.0M | ||
| Q1 24 | $-38.7M | $11.2M |
自由现金流NEWTPBYI
| Q4 25 | $-579.3M | $14.4M | ||
| Q3 25 | $-167.3M | $9.7M | ||
| Q2 25 | $-199.9M | $14.1M | ||
| Q1 25 | $-60.7M | $3.6M | ||
| Q4 24 | $-153.5M | $15.6M | ||
| Q3 24 | $-25.9M | $11.0M | ||
| Q2 24 | $2.9M | $1.0M | ||
| Q1 24 | $-38.7M | — |
自由现金流率NEWTPBYI
| Q4 25 | -790.0% | 19.1% | ||
| Q3 25 | -223.3% | 17.7% | ||
| Q2 25 | -284.7% | 26.8% | ||
| Q1 25 | -91.6% | 7.7% | ||
| Q4 24 | -203.6% | 26.4% | ||
| Q3 24 | -41.2% | 13.7% | ||
| Q2 24 | 4.7% | 2.1% | ||
| Q1 24 | -66.5% | — |
资本支出强度NEWTPBYI
| Q4 25 | 0.1% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.6% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率NEWTPBYI
| Q4 25 | -29.64× | — | ||
| Q3 25 | -9.35× | 1.10× | ||
| Q2 25 | -14.58× | 2.41× | ||
| Q1 25 | -6.48× | 1.21× | ||
| Q4 24 | -8.35× | — | ||
| Q3 24 | -2.15× | 0.54× | ||
| Q2 24 | 0.27× | — | ||
| Q1 24 | -4.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
